Compression behaviour of κ-carrageenan pellets

International Journal of Pharmaceutics

Volumn 390, Issue 2, 2010, Pages 117-127

  Ghanam, D ^a   Hassan, I ^b   Kleinebudde, P ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

Author keywords

Carrageenan; Compression; Deformation; Pellets; SMCC HD 90; Tablets

Indexed keywords

CARRAGEENAN; HYDROCHLOROTHIAZIDE; MICROCRYSTALLINE CELLULOSE; PARACETAMOL; THEOPHYLLINE;

ARTICLE; CONTROLLED STUDY; DRUG PELLET; EMBEDDING; IMAGE ANALYSIS; PELLET EXTRUSION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPHERONIZATION; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET POROSITY; TENSILE STRENGTH;

CARRAGEENAN; CELLULOSE; COMPRESSIVE STRENGTH; DRUG COMPOUNDING; DRUG IMPLANTS; HARDNESS; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; SOLUBILITY; SURFACE PROPERTIES; TABLETS; TENSILE STRENGTH;

EID: 77951499423     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.12.062     Document Type: Article

References (29)

1. Al-Nimry S.S., Assaf S.M., Jalal I.M., Najib N.M. Adsorption of ketotifen onto some pharmaceutical excipients. Int. J. Pharm. 1997, 149:115-121.
2. Beckert T.E., Lehmann K., Schmidt P.C. Compression of enteric-coated pellets to disintegrating tablets. Int. J. Pharm. 1996, 143:13-23.
3. Bodmeier R. Review: tableting of coated pellets. Eur. J. Pharm. Biopharm. 1997, 43:1-8.
4. Bornhöft M., Thommes M., Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation. Eur. J. Pharm. Biopharm. 2005, 59:127-131.
5. Celik M. Compaction of multiparticulate oral dosage forms. Multiparticulate Oral Drug Delivery 1994, 181-216. Marcel Dekker, New York. I. Ghebre-Sellassie (Ed.).
6. Dukic'-Ott A., Thommes M., Remon J.P., Kleinebudde P., Vervaet C. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review. Eur. J. Pharm. Biopharm. 2009, 71:38-46.
7. European Council (ed)., European Pharmacopeia 6th edition, 2008a. Friability of uncoated tablets.Volume 1, 2.9.7. 278-279.
8. European Council (ed)., European Pharmacopeia 6 th edition, 2008b. Uniformity of dosage units. Volume 1, 2.9.40, 327-330.
9. Gehbre-Sellassie I. Pharmaceutical Pelletization Technology 1989, Marcel Dekker, New York, USA.
10. Johansson B., Wikberg M., Ek R., Alderborn G. Compression behaviour and compactibility of microcrystalline cellulose pellets in relationship to their pore structure and mechanical properties. Int. J. Pharm. 1995, 117:57-73.
11. Johansson B., Alderborn G. Degree of pellets deformation during compaction and its relationship to the tensile strength of tablets formed of microcrystalline cellulose pellets. Int. J. Pharm. 1996, 132:207-220.
12. Johansson B., Alderborn G. The effect of shape and porosity on the compression behaviour and tablet forming ability of granular materials formed from microcrystalline cellulose. Eur. J. Pharm. Biopharm. 2001, 52:347-357.
13. Kleinebudde P. Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropylcellulose. II. Swelling properties. Int. J. Pharm. 1994, 109:221-227.
14. Lundqvist A.E.K., Podczeck F., Newton J.M. Influence of disintegrant type and proportion on the properties of tablets produced from mixtures of pellets. Int. J. Pharm. 1997, 147:95-107.
15. Maganti L., Celick M. Compaction studies on pellets. I. Uncoated pellets. Int. J. Pharm. 1993, 95:29-42.
16. Muzikova J., Novakova P. A study of the properties of compacts from silicified microcrystalline celluloses. Drug Dev. Ind. Pharm. 2007, 33:775-781.
17. Nicklasson F., Johansson B., Alderborn G. Occurrence of fragmentation during compression of pellets prepared from a 4 to 1 mixture of dicalcium phosphate dihydrate and microcrystalline cellulose. Eur. J. Pharm. Sci. 1999, 7:221-229.
18. Nicklasson F., Johansson B., Alderborn G. Tabletting behaviour of pellets of a series of porosities-a comparison between pellets of two different compositions. Eur. J. Pharm. Sci. 1999, 8:11-17.
19. Nordström J., Welch K., Frenning G., Alderborn G. On the physical interpretation of the Kawakita and Adams parameters derived form confined compression of granular solids. P. Tech 2008, 182:424-435.
20. Okada S., Nakahara H., Isaka H. Adsorption of drugs on microcrystalline cellulose suspended in aqueous solutions. Chem. Pharm. Bull. 1987, 35:761-768.
21. Picker K.M. The use of carrageenan in mixture with microcrystalline cellulose and its functionality for making tablets. Eur. J. Pharm. Biopharm. 1999, 48:27-36.
22. Pitt K.G., Newton J.M., Rowley G. Tensile fracture of doubly-convex cylindrical discs under diametral loading. J. Mater. Sci. 1988, 28:2723-2728.
23. Rivera S.L., Ghodbane S. In-vitro adsorption-desorption of famotidine on microcrystalline cellulose. Int. J. Pharm. 1994, 108:31-38.
24. Salako M., Podczeck F., Newton J.M. Investigation into the deformability and tensile strength of pellets. Int. J. Pharm. 1998, 168:49-57.
25. Santos H., Veiga F., Pina M.E., Sousa J.J. Compaction, compression and drug release characteristics of xanthan gum pellets of different compositions. Eur. J. Pharm. Sci. 2004, 21:271-281.
26. Thommes M., Kleinebudde P. Use of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur. J. Pharm. Biopharm. 2006, 63:59-67.
27. Thommes M., Kleinebudde P. Use of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Eur. J. Pharm. Biopharm. 2006, 63:68-75.
28. Wickberg M., Alderborn G. Compression characteristics of granulated materials. V. Mechanical properties of individual granules, assessed by diametrical compression in granulations with different volume reduction behaviour. STP Pharm. Sci. 1992, 2:313-319.
29. Zimm K.R., Schwartz J.B., O'Connor R.E. Drug release from a multiparticulate pellet system. Pharm. Dev. Technol. 1996, 1:37-42.